HEALTH CATALYST, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $311.1M | $306.6M | $295.9M | $276.2M | $241.9M | $188.8M | $154.9M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $49.8M | $58.0M | $72.6M | $75.7M | $62.7M | $53.5M | $46.3M |
| SG&A Expense | — | $49.6M | $56.8M | $76.6M | $61.7M | $85.9M | $59.2M | $31.7M |
| Operating Income | — | $-160.9M | $-69.8M | $-126.9M | $-140.0M | $-143.7M | $-96.1M | $-54.9M |
| Operating Margin | — | -51.7% | -22.8% | -42.9% | -50.7% | -59.4% | -50.9% | -35.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $-177.3M | $-69.2M | $-117.8M | — | — | — | — |
| Income Tax Expense | — | $716.0K | $333.0K | $356.0K | $-4.3M | $-6.9M | $-1.2M | $142.0K |
| Net Income | — | $-178.0M | $-69.5M | $-118.1M | $-137.4M | $-153.2M | $-115.0M | $-60.1M |
| Net Margin | — | -57.2% | -22.7% | -39.9% | -49.7% | -63.3% | -60.9% | -38.8% |
| EPS (Basic) | — | $-2.55 | $-1.15 | $-2.09 | $-2.56 | $-3.23 | $-2.91 | $-6.43 |
| EPS (Diluted) | — | $-2.55 | $-1.15 | $-2.09 | $-2.63 | $-3.23 | $-2.91 | $-6.43 |
| Shares Outstanding (Basic) | 73.6M | 69.9M | 60.2M | 56.4M | 53.7M | 47.5M | 39.5M | 37.5M |
| Shares Outstanding (Diluted) | 73.6M | 69.9M | 60.2M | 56.4M | 54.1M | 47.5M | 39.5M | 37.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |